Rebecca Harris

Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells

H. Laman, C. Frezza, A. Natarajan, 2021, bioRxiv.

A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells.

Qiulian Wu, J. Rantala, J. Wohlschlegel, 2022, Molecular cell.

Loss of FBXO7 results in a Parkinson's‐like dopaminergic degeneration via an RPL23–MDM2–TP53 pathway

J. Dalley, R. Barker, H. Laman, 2019, The Journal of pathology.

Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells

H. Laman, S. Randle, Rebecca Harris, 2019, bioRxiv.